Hemagen Diagnostics Market capitalization 2024

The Hemagen Diagnostics Market capitalization history

YEAR	REVENUE (undefined USD)	GROSS MARGIN (%)	NET INCOME (undefined USD)
2012	4.04	39,92	-907.32
2011	5.14	38,14	-880.48
2010	5.22	45,14	-156.31
2009	5.42	38,25	-807
2008	6.38	43,48	428
2007	4.49	41,92	-850
2006	4.78	39,75	310
2005	7.59	25,16	-1,340
2004	7.47	28,78	-3,600
2003	8.47	35,30	-1,270
2002	9.5	30,95	-1,760
2001	10.97	31,08	-2,200
2000	11	12,55	-5,130
1999	14.59	21,80	-5,160
1998	12.33	40,79	10
1997	12.99	41,49	410
1996	10.22	38,85	-460
1995	3.96	44,70	-990
1994	2.36	50,00	-1,110
1993	1.81	58,56	-1,250

Hemagen Diagnostics Aktienanalyse

What does Hemagen Diagnostics do?

Hemagen Diagnostics Inc is a company that was founded in 1985. The company is based in Columbia, Maryland and is involved in medical diagnostics. Hemagen specializes in the development of diagnostic test kits that help doctors and laboratories identify and treat medical conditions and diseases. Hemagen Diagnostics offers a wide range of products in the field of diagnostics and medical research. Their offerings include diagnostic test kits for autoimmune diseases, infectious diseases, enzymes, proteins, and hormones. These test kits are used by medical professionals and laboratories worldwide. The business model of Hemagen Diagnostics is focused on providing its customers with the best diagnostic test kits on the market. The company has developed a wide range of products and services for a broad spectrum of medical conditions and diseases. Hemagen Diagnostics' core business is the production of test kits for laboratories and medical professionals. One of Hemagen Diagnostics' main areas of focus is disease diagnosis. The company has developed an extensive range of diagnostic test kits that facilitate the diagnosis of various diseases. This includes test kits for diseases such as HIV, hepatitis, and infectious diseases like chlamydia and gonorrhea. Hemagen also produces test kits for autoimmune diseases such as rheumatoid arthritis and lupus. Another focus of Hemagen Diagnostics is the development of test kits for medical research. The company has created a wide selection of test kits that can be used for research projects. This includes test kits for hormones, proteins, and enzymes. These test kits are suitable for a range of research applications such as biomarker identification and the study of metabolic processes. Over the years, Hemagen Diagnostics has expanded and improved its range of products and services. The company has continuously expanded and enhanced its division for the development of diagnostic test kits. It has also established a number of partnerships with other companies and institutes in the field of medical diagnostics. In conclusion, Hemagen Diagnostics Inc is a leading provider of diagnostic test kits for medical diagnostics and research. The company specializes in the development of state-of-the-art tests for disease diagnosis and the investigation of biomolecular processes. Hemagen Diagnostics has a strong reputation within the medical community and is continuously working on improving and expanding its product range. Hemagen Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Hemagen Diagnostics's Market Capitalization

Hemagen Diagnostics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Hemagen Diagnostics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Hemagen Diagnostics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Hemagen Diagnostics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Hemagen Diagnostics Stock

What is the current Hemagen Diagnostics market capitalization?

The current market capitalization of Hemagen Diagnostics is 15.5 USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Hemagen Diagnostics.

How has the market capitalization of Hemagen Diagnostics developed in recent years?

The market capitalization of Hemagen Diagnostics has increased/decreased by -99% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Hemagen Diagnostics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Hemagen Diagnostics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Hemagen Diagnostics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Hemagen Diagnostics pay?

Over the past 12 months, Hemagen Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hemagen Diagnostics is expected to pay a dividend of 0 USD.

What is the dividend yield of Hemagen Diagnostics?

The current dividend yield of Hemagen Diagnostics is .

When does Hemagen Diagnostics pay dividends?

Hemagen Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hemagen Diagnostics?

Hemagen Diagnostics paid dividends every year for the past 0 years.

What is the dividend of Hemagen Diagnostics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hemagen Diagnostics located?

Hemagen Diagnostics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hemagen Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hemagen Diagnostics from 7/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/2/2024.

When did Hemagen Diagnostics pay the last dividend?

The last dividend was paid out on 7/2/2024.

What was the dividend of Hemagen Diagnostics in the year 2023?

In the year 2023, Hemagen Diagnostics distributed 0 USD as dividends.

In which currency does Hemagen Diagnostics pay out the dividend?

The dividends of Hemagen Diagnostics are distributed in USD.